Skip to main content
REGN
NASDAQ Life Sciences

Regeneron Posts $18.45 Q3 EPS as Shares Sit Near 52-Week High

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$835
Mkt Cap
$84.296B
52W Low
$591.52
52W High
$859.34
52W Position info
41% above low
Off High info
2.8% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

REGN sits 41% above its 52-week low of $591.52.

Summary

Regeneron reported third-quarter adjusted EPS of $20.07, a step up from the $14.29 non-GAAP EPS it posted for Q2 2026, alongside net income of $1.95B on revenue of $5.12B, with revenue up 36% and non-GAAP EPS up 70%. Dupixent global net sales recorded by Sanofi rose 35% to $6.5B, and Eylea HD U.S. net sales rose 62% to $699M. The print lands with the stock at $835, just below its 52-week high of $859.34, so expectations were already elevated. The quarter follows a heavy stretch of pipeline news — FDA approval of Pasatru in August, the expanded Sanofi antibody collaboration in October, and positive COURAGE and ubamatamab data — giving the beat a broader commercial-plus-pipeline backdrop. Regeneron now sees 2026 adjusted gross margin of about 86%, up from its prior view of 84%-85%.

At the time of this announcement, REGN was trading at $835.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $84.3B. The 52-week trading range was $591.52 to $859.34. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

REGN - Latest Insights

REGN
Nov 08, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $900.00
Real-time Price: $950.03 info
Change: +$50.03 (+6%) info
Market Cap: $98.825B info
REGN
Oct 30, 2026, 12:34 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $910.52
Real-time Price: $950.03 info
Change: +$39.51 (+4%) info
Market Cap: $98.825B info
REGN
Oct 30, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $856.00
Real-time Price: $950.03 info
Change: +$94.03 (+11%) info
Market Cap: $98.825B info
REGN
Oct 12, 2026, 12:06 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $764.45
Real-time Price: $950.03 info
Change: +$185.58 (+24%) info
Market Cap: $98.825B info
REGN
Oct 06, 2026, 7:51 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $721.96
Real-time Price: $950.03 info
Change: +$228.07 (+32%) info
Market Cap: $98.825B info